Abstract:The relationship of copper dyshomeostasis with neurodegenerative diseases has become evident in the last years. Because of the major role that this metal ion plays in biological processes, most of which being located in the brain, it is not surprising that changes in its distribution are closely related with the advent of neurodegenerative disorders such as Alzheimer’s disease (AD). An increasing number of works have dealt with this subject in the last years, and opened an intense debate in some points while r… Show more
“…The conditionalaffinity constants of the three peptides have been determined by intrinsic fluorescence measurements, and are two orderso fm agnitude highert han that previously reportedf or Ab . Competitive binding studies based on fluorescencem easurements using either Ab (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16) or bacterial inclusionb odies of Ab42-GFP have confirmed their efficient ability to displace Ab-bound Cu II ions in an irreversible fashion. ThT emission studies have suggested that copper-induced oligomer aggregation of Ab is indeed inhibited in the presence of the peptides, and on adding the peptides to Cu-induced fibrils am odulation of such fibrillation occurred.…”
Section: Resultsmentioning
confidence: 96%
“…As shown above, the three peptides exhibit Cu 2+ ‐binding affinities that are up to two orders of magnitude higher than that displayed by Aβ(1‐40). To confirm their higher proficiency to “capture” copper(II) ions, competitive binding experiments were performed using the non‐aggregating amyloid fragment Aβ(1‐16) ( K cond =1–2×10 7 m −1 ), following the intrinsic fluorescence of the tyrosine residue Tyr10 of the protein and the emission of a fluorescent tripeptide. For these studies, HK C H was preferred because its emission at 410 nm would not interfere with that of Aβ(1‐16) (emission of tyrosine at 305 nm); the excitation wavelength of HK c H is far enough from that of Aβ(1‐16), in contrast to that for HWH (λ exc =275, 300, and 280 nm for tyrosine, the coumarin group of HK C H , and tryptophan, respectively).…”
Section: Resultsmentioning
confidence: 99%
“…It shoulda lso be notedt hat peptide-to-copper ratios of 1:2a nd 2:1d id not showa ny shift of the d-d band (i.e.,f rom that observed for the 1:1c omplex), corroborating that solelyt he 1:1s peciesisf ormed. 1 Ha nd 13 CNMR studies:T he paramagnetism of copper(II) was used to furtheri nvestigate its interaction with the tripeptides, taking advantage of the severe broadening of the NMR signals upon copperb inding. [33] The 1 Ha nd 13 CNMR spectra for HWH, HK C H,a nd HAH in the presence of 0.01 equivofc opper(II) are shown in the Supporting Information (Figures S5-S10).…”
Section: Resultsmentioning
confidence: 99%
“…Competitiveb inding studies between the tripeptides and amyloidp roteins [Ab (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16) and Ab(1-42)]:A so utlined above,t he tripeptides HWH, HK C H,a nd HAH were selected with the idea of using them as potential binding compounds to competew ith amyloid-b fragments for copper.A ss hown above,t he three peptides exhibit Cu 2 + -binding affinitiest hat are up to two orders of magnitude highert han that displayed by Ab .T oc onfirmt heir higherp roficiency to "capture" copper(II) ions, competitive binding experiments were performed using the non-aggregating amyloid fragment Ab(1-16) (K cond = 1-2 10 7 m À1 ), [1] following the intrinsic fluorescence of the tyrosine residue Tyr10 of the protein and the emissiono f af luorescent tripeptide. For these studies, HK C H was preferred because its emission at 410 nm would not interferew ith that of Ab(1-16) (emission of tyrosine at 305 nm);t he excitation wavelength of HK c H is far enough from that of Ab (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16), in contrastt ot hat for HWH (l exc = 275, 300, and2 80 nm for tyrosine, the coumarin group of HK C H,a nd tryptophan, respectively).…”
Section: Resultsmentioning
confidence: 99%
“…Recent years have witnessed increasing evidence on the relationship betweencopperd yshomeostasis, amongo ther metal ions such as iron and zinc, and the advent of neurodegenerative disorders such as Alzheimer's disease (AD). [1,2] Copper can bind to amyloid beta-protein (Ab)a nd modulate its aggregation mechanism,a nd indeed Ab aggregates represent one of the hallmarks of AD. [3] The binding of copperi ons to the protein promotes the generation of soluble oligomerics pecies, which are believed to be the most toxic form of Ab.…”
Brain copper imbalance plays an important role in amyloid-β aggregation, tau hyperphosphorylation, and neurotoxicity observed in Alzheimer's disease (AD). Therefore, the administration of biocompatible metal-binding agents may offer a potential therapeutic solution to target mislocalized copper ions and restore metallostasis. Histidine-containing peptides and proteins are excellent metal binders and are found in many natural systems. The design of short peptides showing optimal binding properties represents a promising approach to capture and redistribute mislocalized metal ions, mainly due to their biocompatibility, ease of synthesis, and the possibility of fine-tuning their metal-binding affinities in order to suppress unwanted competitive binding with copper-containing proteins. In the present study, three peptides, namely HWH, HK(C) H, and HAH, have been designed with the objective of reducing copper toxicity in AD. These tripeptides form highly stable albumin-like complexes, showing higher affinity for Cu(II) than that of Aβ(1-40). Furthermore, HWH, HK(C) H, and HAH act as very efficient inhibitors of copper-mediated reactive oxygen species (ROS) generation and prevent the copper-induced overproduction of toxic oligomers in the initial steps of amyloid aggregation in the presence of Cu(II) ions. These tripeptides, and more generally small peptides including the sequence His-Xaa-His at the N-terminus, may therefore be considered as promising motifs for the future development of new and efficient anti-Alzheimer drugs.
“…The conditionalaffinity constants of the three peptides have been determined by intrinsic fluorescence measurements, and are two orderso fm agnitude highert han that previously reportedf or Ab . Competitive binding studies based on fluorescencem easurements using either Ab (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16) or bacterial inclusionb odies of Ab42-GFP have confirmed their efficient ability to displace Ab-bound Cu II ions in an irreversible fashion. ThT emission studies have suggested that copper-induced oligomer aggregation of Ab is indeed inhibited in the presence of the peptides, and on adding the peptides to Cu-induced fibrils am odulation of such fibrillation occurred.…”
Section: Resultsmentioning
confidence: 96%
“…As shown above, the three peptides exhibit Cu 2+ ‐binding affinities that are up to two orders of magnitude higher than that displayed by Aβ(1‐40). To confirm their higher proficiency to “capture” copper(II) ions, competitive binding experiments were performed using the non‐aggregating amyloid fragment Aβ(1‐16) ( K cond =1–2×10 7 m −1 ), following the intrinsic fluorescence of the tyrosine residue Tyr10 of the protein and the emission of a fluorescent tripeptide. For these studies, HK C H was preferred because its emission at 410 nm would not interfere with that of Aβ(1‐16) (emission of tyrosine at 305 nm); the excitation wavelength of HK c H is far enough from that of Aβ(1‐16), in contrast to that for HWH (λ exc =275, 300, and 280 nm for tyrosine, the coumarin group of HK C H , and tryptophan, respectively).…”
Section: Resultsmentioning
confidence: 99%
“…It shoulda lso be notedt hat peptide-to-copper ratios of 1:2a nd 2:1d id not showa ny shift of the d-d band (i.e.,f rom that observed for the 1:1c omplex), corroborating that solelyt he 1:1s peciesisf ormed. 1 Ha nd 13 CNMR studies:T he paramagnetism of copper(II) was used to furtheri nvestigate its interaction with the tripeptides, taking advantage of the severe broadening of the NMR signals upon copperb inding. [33] The 1 Ha nd 13 CNMR spectra for HWH, HK C H,a nd HAH in the presence of 0.01 equivofc opper(II) are shown in the Supporting Information (Figures S5-S10).…”
Section: Resultsmentioning
confidence: 99%
“…Competitiveb inding studies between the tripeptides and amyloidp roteins [Ab (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16) and Ab(1-42)]:A so utlined above,t he tripeptides HWH, HK C H,a nd HAH were selected with the idea of using them as potential binding compounds to competew ith amyloid-b fragments for copper.A ss hown above,t he three peptides exhibit Cu 2 + -binding affinitiest hat are up to two orders of magnitude highert han that displayed by Ab .T oc onfirmt heir higherp roficiency to "capture" copper(II) ions, competitive binding experiments were performed using the non-aggregating amyloid fragment Ab(1-16) (K cond = 1-2 10 7 m À1 ), [1] following the intrinsic fluorescence of the tyrosine residue Tyr10 of the protein and the emissiono f af luorescent tripeptide. For these studies, HK C H was preferred because its emission at 410 nm would not interferew ith that of Ab(1-16) (emission of tyrosine at 305 nm);t he excitation wavelength of HK c H is far enough from that of Ab (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16), in contrastt ot hat for HWH (l exc = 275, 300, and2 80 nm for tyrosine, the coumarin group of HK C H,a nd tryptophan, respectively).…”
Section: Resultsmentioning
confidence: 99%
“…Recent years have witnessed increasing evidence on the relationship betweencopperd yshomeostasis, amongo ther metal ions such as iron and zinc, and the advent of neurodegenerative disorders such as Alzheimer's disease (AD). [1,2] Copper can bind to amyloid beta-protein (Ab)a nd modulate its aggregation mechanism,a nd indeed Ab aggregates represent one of the hallmarks of AD. [3] The binding of copperi ons to the protein promotes the generation of soluble oligomerics pecies, which are believed to be the most toxic form of Ab.…”
Brain copper imbalance plays an important role in amyloid-β aggregation, tau hyperphosphorylation, and neurotoxicity observed in Alzheimer's disease (AD). Therefore, the administration of biocompatible metal-binding agents may offer a potential therapeutic solution to target mislocalized copper ions and restore metallostasis. Histidine-containing peptides and proteins are excellent metal binders and are found in many natural systems. The design of short peptides showing optimal binding properties represents a promising approach to capture and redistribute mislocalized metal ions, mainly due to their biocompatibility, ease of synthesis, and the possibility of fine-tuning their metal-binding affinities in order to suppress unwanted competitive binding with copper-containing proteins. In the present study, three peptides, namely HWH, HK(C) H, and HAH, have been designed with the objective of reducing copper toxicity in AD. These tripeptides form highly stable albumin-like complexes, showing higher affinity for Cu(II) than that of Aβ(1-40). Furthermore, HWH, HK(C) H, and HAH act as very efficient inhibitors of copper-mediated reactive oxygen species (ROS) generation and prevent the copper-induced overproduction of toxic oligomers in the initial steps of amyloid aggregation in the presence of Cu(II) ions. These tripeptides, and more generally small peptides including the sequence His-Xaa-His at the N-terminus, may therefore be considered as promising motifs for the future development of new and efficient anti-Alzheimer drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.